SCHEDULE: Millennium Entities Disclose 6.5% Stake in Cryoport
Beneficial Ownership Disclosure
Millennium Management and affiliated entities have disclosed a 6.5% beneficial ownership stake in Cryoport, Inc. common stock.
Summary
- Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in Cryoport, Inc.
- Integrated Core Strategies (US) LLC beneficially owns 3,231,470 shares of Cryoport, Inc. common stock, representing 6.5% of the class.
- Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each beneficially own 3,244,802 shares of Cryoport, Inc. common stock, also representing 6.5% of the class.
- All reporting persons hold shared voting and dispositive power over their respective beneficially owned shares.
- The securities were not acquired or held for the purpose of changing or influencing the control of Cryoport, Inc.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership by an institutional investor and does not contain operational or financial performance data.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that Schedule 13G filings are standard disclosures by institutional investors who acquire more than 5% of a company's stock but do not intend to influence or change control of the issuer. This filing indicates a significant passive investment by Millennium Management and its affiliates in Cryoport, a company operating in the life sciences logistics sector.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Millennium Management and its affiliates could be viewed positively, indicating institutional confidence in Cryoport, Inc. However, as a passive investment, it does not suggest immediate strategic changes.
- Company Management: Awareness of a large institutional shareholder may influence management's focus on long-term value creation, though the filing explicitly states no intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires the filing of this statement. |
| 02/04/2026 | Filing date of the Schedule 13G Amendment No. 1. |
Keywords
Cryoport Inc, Millennium Management, Integrated Core Strategies, Israel A. Englander, Beneficial Ownership, Schedule 13G, Institutional Investor, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.